Rapifen
As listed in the register: Rapifen, Injektions-/Infusionslösung
·
- Prescription status not stated
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Alfentanilum
- Made by
- Piramal Critical Care Limited, London, Zweigniederlassung Rüschlikon
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Narco-Analgeticum zur Anästhesie
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Piramal Critical Care Limited, London, Zweigniederlassung Rüschlikon |
|---|---|
| Active substance | Alfentanilum |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Classification | N01AH02 · Pain, sleep, mood, epilepsy and the brain |
| Dispensing (as stated by the register) | Abgabekategorie A+ |
| Name in the register | Rapifen, Injektions-/Infusionslösung |
| Packs | 10 x 2 ml Ampulle(n) · 10 x 10 ml Ampulle(n) · 5 x 2 ml Ampulle(n) · 50 x 10 ml Ampulle(n) |
| Zulassungsnummer | 45204 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.